Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial

NCT05610319 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT05610319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05610319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial
Lead sponsor
McMaster University
Phase
Phase 4
Overall status
Active, not recruiting
Start date
May 1, 2023
Completion date
December 31, 2026
Enrollment
446 (estimated)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema